Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 598

1.

BCL2 and JUNB abnormalities in primary cutaneous lymphomas.

Mao X, Orchard G, Lillington DM, Child FJ, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

Br J Dermatol. 2004 Sep;151(3):546-56.

PMID:
15377339
2.

Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.

Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ.

Blood. 2003 Feb 15;101(4):1513-9. Epub 2002 Oct 3.

3.

Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.

Mao X, Orchard G, Russell-Jones R, Whittaker S.

Br J Dermatol. 2007 Nov;157(5):914-21. Epub 2007 Aug 24.

PMID:
17725669
4.

Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.

Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker S.

Genes Chromosomes Cancer. 2003 Jun;37(2):176-85.

PMID:
12696066
5.

Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.

Child FJ, Russell-Jones R, Woolford AJ, Calonje E, Photiou A, Orchard G, Whittaker SJ.

Br J Dermatol. 2001 Apr;144(4):735-44.

PMID:
11298531
6.

A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS.

Mao X, Orchard G, Mitchell TJ, Oyama N, Russell-Jones R, Vermeer MH, Willemze R, van Doorn R, Tensen CP, Young BD, Whittaker SJ.

J Cutan Pathol. 2008 Oct;35(10):899-910. doi: 10.1111/j.1600-0560.2007.00924.x. Epub 2008 Jun 28.

PMID:
18494816
7.

Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.

Mao X, Orchard G.

Br J Dermatol. 2008 Jul;159(1):145-51. doi: 10.1111/j.1365-2133.2008.08579.x. Epub 2008 Jul 1.

PMID:
18460027
8.

Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.

Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R, Young B, Whittaker SJ.

Br J Dermatol. 2002 Sep;147(3):464-75.

PMID:
12207585
9.

Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.

Mao X, Orchard G, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

J Invest Dermatol. 2006 Jun;126(6):1388-95.

10.

Primary cutaneous B-cell lymphoma in Japanese patients.

Liu Q, Ohshima K, Kikuchi M.

Pathol Int. 2000 Dec;50(12):960-6.

PMID:
11123762
11.

Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.

Mao X, Lillington D, Child F, Russell-Jones R, Young B, Whittaker S.

Genes Chromosomes Cancer. 2002 Oct;35(2):144-55.

PMID:
12203778
12.

Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.

Benner MF, Jansen PM, Meijer CJ, Willemze R.

Br J Dermatol. 2009 Jul;161(1):121-7. doi: 10.1111/j.1365-2133.2009.09147.x. Epub 2009 Apr 16.

PMID:
19416236
13.

Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.

Willenbrock K, Küppers R, Renné C, Brune V, Eckerle S, Weidmann E, Bräuninger A, Hansmann ML.

Haematologica. 2006 May;91(5):596-604.

14.

Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 years.

Bergman R, Marcus-Farber BS, Manov L, Nerodinisky I, Epelbaum R, Sahar D, Schein-Goldschmid R, Ramon M, Ben-Arieh Y.

Int J Dermatol. 2002 Nov;41(11):735-43.

PMID:
12452994
15.

Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.

Vergier B, Belaud-Rotureau MA, Benassy MN, Beylot-Barry M, Dubus P, Delaunay M, Garroste JC, Taine L, Merlio JP.

Am J Surg Pathol. 2004 Jun;28(6):748-55.

PMID:
15166666
17.

CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.

Laharanne E, Chevret E, Idrissi Y, Gentil C, Longy M, Ferrer J, Dubus P, Jouary T, Vergier B, Beylot-Barry M, Merlio JP.

Mod Pathol. 2010 Apr;23(4):547-58. doi: 10.1038/modpathol.2009.196. Epub 2010 Jan 29.

18.

Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.

McCluggage WG, Catherwood M, Alexander HD, McBride HA, Smith ME, Morris TC.

Histopathology. 2002 Nov;41(5):414-20.

PMID:
12405909
19.

Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.

Hahtola S, Tuomela S, Elo L, Häkkinen T, Karenko L, Nedoszytko B, Heikkilä H, Saarialho-Kere U, Roszkiewicz J, Aittokallio T, Lahesmaa R, Ranki A.

Clin Cancer Res. 2006 Aug 15;12(16):4812-21.

20.

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.

Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK.

Genes Chromosomes Cancer. 1998 Jun;22(2):114-21.

PMID:
9598798

Supplemental Content

Support Center